Valneva SE Stock
Valneva SE Stock
Valneva SE shows a slight decrease today, losing -€0.012 (-0.330%) compared to yesterday.
The community is currently still undecided about Valneva SE with 2 Buy predictions and 0 Sell predictions.
With a target price of 7 € there is a hugely positive potential of 91.36% for Valneva SE compared to the current price of 3.66 €.
Our community identified positive and negative aspects for Valneva SE stock for the coming years. 10 users see the criterium "Worthwhile Investment for the next years" as a plus for the Valneva SE stock. On the other hand our users think that "Balance Sheet Risk" could be a problem in the future.
Pros and Cons of Valneva SE in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Valneva SE vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Valneva SE | -0.330% | -7.157% | 3.304% | -24.139% | -23.296% | -71.129% | 4.514% |
| Nanobiotix | -2.320% | -7.261% | -10.391% | 50.373% | -21.417% | -63.067% | -56.621% |
| Transgene S.A. | 2.690% | 11.692% | 31.047% | -26.888% | 8.358% | -44.580% | -49.671% |
| Quantum Genomics S.A. | 0.400% | 7.265% | 7.725% | -17.298% | 14.091% | -97.715% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-11
Upon initial examination, the financial standing of Valneva, a company in the Biotechnology & Medical Research industry, is a mix of strengths and weaknesses. The company appears to be investing heavily in research and development, which is typical for firms in this sector. However, a thorough analysis of their financial statements reveals several key areas of concern, as well as areas of opportunity.
*Pros: *
Increased Revenue: Valneva's revenue has been steadily increasing - from 110,321,000 EUR in 2020 to 348,085,000 EUR in 2021 and 361,303,000 EUR in 2022. This positive trend indicates that the company is successfully growing its business and generating higher income.
